Sandeep Kumar

Dr. Sandeep Kumar

Director, Drug Development Consulting

About

Dr. Sandeep Kumar serves as Director, Drug Development Consulting at Quotient Sciences, where he leads the design of Translational Pharmaceutics® programs and develops product strategies tailored to customer needs. With over 10 years of experience spanning formulation development, clinical trial manufacturing, excipient and coating technologies, Dr. Kumar brings extensive expertise from roles in academia, large and midsize CDMOs, and the excipient industry.

He is an inventor on multiple formulation patents and has authored numerous research articles. Dr. Kumar’s expertise covers the full spectrum of drug product development—from early-stage formulation through to late-stage development and commercial readiness. He is particularly passionate about supporting early-stage drug development customers in bringing differentiated products to market.

Dr. Kumar holds a Ph.D. in Pharmacy from Queen’s University Belfast, Northern Ireland, UK. His commitment to scientific excellence and customer-focused solutions ensures that clients benefit from robust, efficient, and innovative drug development pathways.

Quotient Sciences Logo
Drug Development Consulting, Translational Pharmaceutics, Formulation Development, Drug Product, Careers

The Strategic Role of Drug Development Consultants at Quotient Sciences

Read More

Latest news from Quotient Sciences

More News
News & Announcements, Articles & Publications, commercial manufacturing, Dr. Helen Baker, Dr. Richard Castledine Dr. Helen Baker and Dr. Richard Castledine contribute to Pharmaceutical Technology's 'Poor API Quality Threatens a Healthy Supply' By: Dr. Helen Baker and Dr. Richard Castledine
Read More
News & Announcements, Articles & Publications, Thierry Van Nieuwenhove Thierry Van Nieuwenhove on the Future of CDMO Partnerships By: Thierry Van Nieuwenhove
Read More
News & Announcements, Translational Pharmaceutics®, Articles & Publications BioPharm International interviews Helen Baker about how Quotient Sciences is optimizing drug development
Read More